Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > We seem to be on the cusp of change in Medical Treatment !
View:
Post by Oden6570 on Feb 09, 2024 3:18am

We seem to be on the cusp of change in Medical Treatment !

The possibilities for Theralase to grow and branch out in many novel and new medical trends and treatments is enormus IMHO. However the simple fact that we have no funding currently to exploit our oppurtunities is very frustrating to me. 

Wetre doyou believe relationship with Li Ka Shing Knowledge Institute fits in to the big picture ? 

Light therapy helmet could help dementia patients - Bioscience Today

Theralase launches Anti-Cancer Therapy Research Centre – Theralase Technologies
Comment by Oilminerdeluxe on Feb 09, 2024 3:26am
Only takes one thing. Money! Dear lord, the possibilities if Theralse was able to run wild. Uncle Elon could sponsor us with a billio or two. If we named the company Theralase X or something.
Comment by DeathXray33 on Feb 09, 2024 7:19am
I'll still be a buyer @ $5. They tried to stop Elon from selling his automobiles... I'm buying more Monday...
Comment by Legit62 on Feb 09, 2024 9:04am
Oden, we have not been derisked yet, once BTD and AA dont worry about funds. This is a long process to get it right or every small biotech would have a drug to market every day. One of the problems i see here is alot of investors got into this years ago when it was a big dream. Well now is the time to be buying this stock IMO. we are on the verge of something great with a little bit of more ...more  
Comment by tdon1229 on Feb 09, 2024 2:16pm
To see the state of the science, head over to the Bit Chute site and search for "end of germ theory." I think you'll find it to be excellent viewing right from the start.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250